{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:01:37Z","timestamp":1793037697447,"version":"4.5.0"},"reference-count":169,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,26]]},"DOI":"10.1093\/ecco-jcc\/jjy191","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T07:47:25Z","timestamp":1542095245000},"page":"541-554","source":"Crossref","is-referenced-by-count":201,"title":["The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-8516","authenticated-orcid":false,"given":"C R H","family":"Hedin","sequence":"first","affiliation":[{"name":"Gastroenterology unit, Patient Area Gastroenterology, Dermatovenereology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Vavricka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Stagg","sequence":"additional","affiliation":[{"name":"Centre for Immunobiology, Bart\u2019s and The London Medical School, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schoepfer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Raine","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Addenbrooke\u2019s Hospital, Cambridge University Teaching Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital de la Santa Creu i Sant Pau. Universitat Aut\u00f2noma de Barcelona, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Pleyer","sequence":"additional","affiliation":[{"name":"University Eye Clinic, Uveitis Center, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Navarini","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A E","family":"van der Meulen-de Jong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Maul","sequence":"additional","affiliation":[{"name":"Gastroenterologie am Bayerischen Platz, Berlin, Germany"},{"name":"Department of Medicine (Gastroenterology, Infectious Diseases, Rheumatology), Campus Benjamin Franklin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Katsanos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Medical School, University of Ioannina School of Medical Sciences, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kagramanova","sequence":"additional","affiliation":[{"name":"IBD Department, The Loginov Moscow Clinical Scientific Centre, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Greuter","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland"},{"name":"Gastroenterology Research Unit, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Gonz\u00e1lez-Lama","sequence":"additional","affiliation":[{"name":"IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"van Gaalen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center [LUMC], Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ellul","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Mater Dei Hospital, Msida, Malta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Burisch","sequence":"additional","affiliation":[{"name":"Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark"},{"name":"Abdominal Center K, Medical Section, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bettenworth","sequence":"additional","affiliation":[{"name":"Department of Medicine B, Gastroenterology and Hepatology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Triemli Hospital, Zurich, Switzerland & Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Bamias","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, GI Unit, 3rd Academic Department of Internal Medicine, Sotiria Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Rieder","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutrition; Digestive Diseases and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"2019042621331431600_CIT0001","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331431600_CIT0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Harbord","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2019042621331431600_CIT0003","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2019042621331431600_CIT0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaut.2016.01.001","article-title":"Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity","volume":"68","author":"Trivedi","year":"2016","journal-title":"J Autoimmun"},{"key":"2019042621331431600_CIT0005","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jhep.2001.24231","article-title":"MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium [MAdCAM-1 in chronic inflammatory liver disease]","volume":"33","author":"Grant","year":"2001","journal-title":"Hepatology"},{"key":"2019042621331431600_CIT0006","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"2019042621331431600_CIT0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2249.2012.04649.x","article-title":"Skin- and gut-homing molecules on human circulating \u03b3\u03b4 T cells and their dysregulation in inflammatory bowel disease","volume":"170","author":"Mann","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"2019042621331431600_CIT0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.181.1.137","article-title":"Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms","volume":"181","author":"Salmi","year":"1995","journal-title":"J Exp Med"},{"key":"2019042621331431600_CIT0009","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.166.7.4650","article-title":"Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules","volume":"166","author":"Salmi","year":"2001","journal-title":"J Immunol"},{"key":"2019042621331431600_CIT0010","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/gast.1996.v110.pm8566600","article-title":"Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium","volume":"110","author":"McNab","year":"1996","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0011","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4049\/jimmunol.169.2.983","article-title":"Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells","volume":"169","author":"Lalor","year":"2002","journal-title":"J Immunol"},{"key":"2019042621331431600_CIT0012","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/1521-4141(200003)30:3<819::AID-IMMU819>3.0.CO;2-Y","article-title":"Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation","volume":"30","author":"Agace","year":"2000","journal-title":"Eur J Immunol"},{"key":"2019042621331431600_CIT0013","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00054725-200111000-00001","article-title":"Chemokine receptor CXCR3 expression in inflammatory bowel disease","volume":"7","author":"Yuan","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331431600_CIT0014","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.berh.2014.10.009","article-title":"The role of mechanical stress in the pathogenesis of spondyloarthritis and how to combat it","volume":"28","author":"Jacques","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2019042621331431600_CIT0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"2019042621331431600_CIT0016","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.13552","article-title":"The features of mucosa-associated microbiota in primary sclerosing cholangitis","volume":"43","author":"Torres","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2019042621331431600_CIT0017","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","article-title":"Characterization of intestinal microbiota in ulcerative colitis patients with and without primary sclerosing cholangitis","volume":"10","author":"Kevans","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2019042621331431600_CIT0018","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(95)91089-1","article-title":"HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: Implications for spondyloarthropathies","volume":"345","author":"Scofield","year":"1995","journal-title":"Lancet"},{"key":"2019042621331431600_CIT0019","doi-asserted-by":"crossref","first-page":"37573","DOI":"10.1074\/jbc.M205470200","article-title":"Molecular mimicry of an HLA-B27\u2013derived ligand of arthritis-linked subtypes with chlamydial proteins","volume":"277","author":"Ramos","year":"2002","journal-title":"J Biol Chem"},{"key":"2019042621331431600_CIT0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.07.014","article-title":"Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site","volume":"43","author":"Horai","year":"2015","journal-title":"Immunity"},{"key":"2019042621331431600_CIT0021","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1038\/s41598-017-12163-3","article-title":"Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine","volume":"7","author":"Nakamura","year":"2017","journal-title":"Sci Rep"},{"key":"2019042621331431600_CIT0022","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840030203","article-title":"Elevated circulating immune complexes in primary sclerosing cholangitis","volume":"3","author":"Bodenheimer","year":"1983","journal-title":"Hepatology"},{"key":"2019042621331431600_CIT0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0016-5085(95)90263-5","article-title":"Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis","volume":"109","author":"Biancone","year":"1995","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0024","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0016-5085(98)70310-5","article-title":"Tropomyosin isoforms in intestinal mucosa: Production of autoantibodies to tropomyosin isoforms in ulcerative colitis","volume":"114","author":"Geng","year":"1998","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4049\/jimmunol.139.1.77","article-title":"The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: Cellular localization of the antigen by using the monoclonal antibody","volume":"139","author":"Das","year":"1987","journal-title":"J Immunol"},{"key":"2019042621331431600_CIT0026","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0016-5085(90)90839-S","article-title":"A shared and unique epitope[s] on human colon, skin, and biliary epithelium detected by a monoclonal antibody","volume":"98","author":"Das","year":"1990","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0027","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0016-5085(94)90066-3","article-title":"A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody","volume":"107","author":"Bhagat","year":"1994","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0028","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrg3502","article-title":"Genetic insights into common pathways and complex relationships among immune-mediated diseases","volume":"14","author":"Parkes","year":"2013","journal-title":"Nat Rev Genet"},{"key":"2019042621331431600_CIT0029","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ecco-jcc\/jjv238","article-title":"Smoking is associated with extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Severs","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2019042621331431600_CIT0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2017.02.013","article-title":"IBD immunopathogenesis: A comprehensive review of inflammatory molecules","volume":"16","author":"Park","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2019042621331431600_CIT0031","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ibd.20019","article-title":"Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease","volume":"13","author":"Pastor Rojo","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331431600_CIT0032","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/gut.33.5.678","article-title":"Increased pulmonary and intestinal permeability in Crohn\u2019s disease","volume":"33","author":"Adenis","year":"1992","journal-title":"Gut"},{"key":"2019042621331431600_CIT0033","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4\u2013CD8\u2013 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"2019042621331431600_CIT0034","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/cs0940461","article-title":"Neutrophil priming: Pathophysiological consequences and underlying mechanisms","volume":"94","author":"Condliffe","year":"1998","journal-title":"Clin Sci [Lond]"},{"key":"2019042621331431600_CIT0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2249.1991.tb02958.x","article-title":"Peripheral blood neutrophils in inflammatory bowel disease: Morphological evidence of in vivo activation in active disease","volume":"86","author":"McCarthy","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2019042621331431600_CIT0036","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.42.4.470","article-title":"Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation","volume":"42","author":"Nikolaus","year":"1998","journal-title":"Gut"},{"key":"2019042621331431600_CIT0037","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.20091233","article-title":"Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn\u2019s disease","volume":"206","author":"Smith","year":"2009","journal-title":"J Exp Med"},{"key":"2019042621331431600_CIT0038","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/j.gastro.2014.01.057","article-title":"Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn\u2019s disease","volume":"146","author":"Sanders","year":"2014","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0039","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nm.2087","article-title":"Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity","volume":"16","author":"Clarke","year":"2010","journal-title":"Nat Med"},{"key":"2019042621331431600_CIT0040","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.1400762","article-title":"Microbiota-derived compounds drive steady-state granulopoiesis via MyD88\/TICAM signaling","volume":"193","author":"Balmer","year":"2014","journal-title":"J Immunol"},{"key":"2019042621331431600_CIT0041","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood-2016-06-723742","article-title":"Sensing of the microbiota by NOD1 in mesenchymal stromal cells regulates murine hematopoiesis","volume":"129","author":"Iwamura","year":"2017","journal-title":"Blood"},{"key":"2019042621331431600_CIT0042","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.chom.2014.02.006","article-title":"Gut microbiota promote hematopoiesis to control bacterial infection","volume":"15","author":"Khosravi","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2019042621331431600_CIT0043","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.immuni.2011.02.016","article-title":"Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands","volume":"34","author":"Shi","year":"2011","journal-title":"Immunity"},{"key":"2019042621331431600_CIT0044","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.immuni.2012.08.025","article-title":"Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23\u2013driven chronic intestinal inflammation","volume":"37","author":"Griseri","year":"2012","journal-title":"Immunity"},{"key":"2019042621331431600_CIT0045","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.immuni.2015.05.011","article-title":"Bone-marrow\u2013resident NK cells prime monocytes for regulatory function during infection","volume":"42","author":"Askenase","year":"2015","journal-title":"Immunity"},{"key":"2019042621331431600_CIT0046","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3444","article-title":"Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis","volume":"20","author":"Trompette","year":"2014","journal-title":"Nat Med"},{"key":"2019042621331431600_CIT0047","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.chom.2013.12.010","article-title":"Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE\u2082","volume":"15","author":"Kim","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2019042621331431600_CIT0048","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal microbiota study reveals specific dysbiosis in spondyloarthritis","volume":"76","author":"Breban","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0049","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/art.39802","article-title":"Brief report: Dialister as a microbial marker of disease activity in spondyloarthritis","volume":"69","author":"Tito","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2019042621331431600_CIT0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2019042621331431600_CIT0051","doi-asserted-by":"crossref","first-page":"e0176955","DOI":"10.1371\/journal.pone.0176955","article-title":"Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by dimethylfumarate therapy [DMF]","volume":"12","author":"Eppinga","year":"2017","journal-title":"PLoS One"},{"key":"2019042621331431600_CIT0052","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"2019042621331431600_CIT0053","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2019042621331431600_CIT0054","doi-asserted-by":"crossref","first-page":"40826","DOI":"10.1038\/srep40826","article-title":"Association of the intestinal microbiome with the development of neovascular age-related macular degeneration","volume":"7","author":"Zinkernagel","year":"2017","journal-title":"Sci Rep"},{"key":"2019042621331431600_CIT0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.preteyeres.2018.01.001","article-title":"Epigenetics, microbiota, and intraocular inflammation: new paradigms of immune regulation in the eye","volume":"64","author":"Wen","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"2019042621331431600_CIT0056","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/19490976.2016.1186334","article-title":"The mucin-degradation strategy of Ruminococcus gnavus: The importance of intramolecular trans-sialidases","volume":"7","author":"Crost","year":"2016","journal-title":"Gut Microbes"},{"key":"2019042621331431600_CIT0057","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1073\/pnas.1006734107","article-title":"Systemic gut microbial modulation of bile acid metabolism in host tissue compartments","volume":"108","author":"Swann","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019042621331431600_CIT0058","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/19490976.2017.1284733","article-title":"The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease","volume":"8","author":"Hedin","year":"2017","journal-title":"Gut Microbes"},{"key":"2019042621331431600_CIT0059","doi-asserted-by":"crossref","first-page":"e34043","DOI":"10.1371\/journal.pone.0034043","article-title":"Patterns of early gut colonization shape future immune responses of the host","volume":"7","author":"Hansen","year":"2012","journal-title":"PLoS One"},{"key":"2019042621331431600_CIT0060","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2015-208187","article-title":"Patients with ankylosing spondylitis have been breast fed less often than healthy controls: A case\u2013control retrospective study","volume":"75","author":"Montoya","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0061","first-page":"987","article-title":"Extraintestinal manifestations and complications in inflammatory bowel disease: From shared genetics to shared biological pathways","volume":"20","author":"van Sommeren","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331431600_CIT0062","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/gut.38.5.738","article-title":"Clinical patterns of familial inflammatory bowel disease","volume":"38","author":"Satsangi","year":"1996","journal-title":"Gut"},{"key":"2019042621331431600_CIT0063","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ecco-jcc\/jjv178","article-title":"Ocular manifestations in inflammatory bowel disease are associated with other extra-intestinal manifestations, gender, and genes implicated in other immune-related traits","volume":"10","author":"Taleban","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2019042621331431600_CIT0064","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2004.021774","article-title":"Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn\u2019s disease","volume":"63","author":"Peeters","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00002281-200207000-00001","article-title":"Anterior uveitis: Current concepts of pathogenesis and interactions with the spondyloarthropathies","volume":"14","author":"Martin","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"2019042621331431600_CIT0066","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"key":"2019042621331431600_CIT0067","doi-asserted-by":"crossref","first-page":"e72594","DOI":"10.1371\/journal.pone.0072594","article-title":"Intestinal-specific TNF\u03b1 overexpression induces Crohn\u2019s-like ileitis in mice","volume":"8","author":"Bamias","year":"2013","journal-title":"PLoS One"},{"key":"2019042621331431600_CIT0068","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/mi.2015.102","article-title":"Host and microbiota interactions are critical for development of murine Crohn\u2019s-like ileitis","volume":"9","author":"Roulis","year":"2016","journal-title":"Mucosal Immunol"},{"key":"2019042621331431600_CIT0069","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1053\/j.gastro.2008.02.085","article-title":"Role of beta7 integrin and the chemokine\/chemokine receptor pair CCL25\/CCR9 in modeled TNF-dependent Crohn\u2019s disease","volume":"134","author":"Apostolaki","year":"2008","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0070","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0092-8674(90)90512-D","article-title":"Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human \u03b22m: An animal model of HLA-B27\u2013associated human disorders","volume":"63","author":"Hammer","year":"1990","journal-title":"Cell"},{"key":"2019042621331431600_CIT0071","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2019042621331431600_CIT0072","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.4049\/jimmunol.175.4.2438","article-title":"HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response","volume":"175","author":"Turner","year":"2005","journal-title":"J Immunol"},{"key":"2019042621331431600_CIT0073","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI118878","article-title":"Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27\/human beta2 microglobulin transgenic rats","volume":"98","author":"Rath","year":"1996","journal-title":"J Clin Invest"},{"key":"2019042621331431600_CIT0074","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.34423","article-title":"\u03b2-glucan triggers spondylarthritis and Crohn\u2019s disease\u2013like ileitis in SKG mice","volume":"64","author":"Ruutu","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2019042621331431600_CIT0075","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.38638","article-title":"Interleukin-23 mediates the intestinal response to microbial \u03b2-1,3-glucan and the development of spondyloarthritis pathology in SKG mice","volume":"66","author":"Benham","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2019042621331431600_CIT0076","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1749-6632.2009.04757.x","article-title":"HLA-B27 transgenic rat: An animal model mimicking gut and joint involvement in human spondyloarthritides","volume":"1173","author":"Milia","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"2019042621331431600_CIT0077","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2036.2009.03955.x","article-title":"Review article: Anti TNF-\u03b1 induced psoriasis in patients with inflammatory bowel disease","volume":"29","author":"Fiorino","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"2019042621331431600_CIT0078","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","article-title":"Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-\u03b1 agents","volume":"13","author":"Fiorino","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2019042621331431600_CIT0079","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019042621331431600_CIT0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-\u03b1 inhibitors in patients with rheumatologic conditions","volume":"143","author":"de Gannes","year":"2007","journal-title":"Arch Dermatol"},{"key":"2019042621331431600_CIT0081","doi-asserted-by":"crossref","first-page":"xiv","DOI":"10.1111\/j.0022-202X.2005.23923.x","article-title":"Defining upstream elements of psoriasis pathogenesis: An emerging role for interferon alpha","volume":"125","author":"Nestle","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2019042621331431600_CIT0082","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12016-017-8617-4","article-title":"Skin manifestations of inflammatory bowel disease","volume":"53","author":"Greuter","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2019042621331431600_CIT0083","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2010.07.022","article-title":"Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy","volume":"8","author":"Rahier","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019042621331431600_CIT0084","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ecco-jcc\/jjx158","article-title":"Expression patterns of TNF\u03b1, MAdCAM1, and STAT3 in intestinal and skin manifestations of inflammatory bowel disease","volume":"12","author":"Vavricka","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2019042621331431600_CIT0085","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/annrheumdis-2016-210233","article-title":"An induction or flare of arthritis and\/or sacroiliitis by vedolizumab in inflammatory bowel disease: A case series","volume":"76","author":"Varkas","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0086","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.14419","article-title":"Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: A multicentre cohort study nested in the OBSERV-IBD cohort","volume":"47","author":"Tadbiri","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2019042621331431600_CIT0087","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.immuni.2011.01.016","article-title":"Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria","volume":"34","author":"Hadis","year":"2011","journal-title":"Immunity"},{"key":"2019042621331431600_CIT0088","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1053\/j.gastro.2011.09.015","article-title":"Gut-tropic T cells that express integrin \u03b14\u03b27 and CCR9 are required for induction of oral immune tolerance in mice","volume":"141","author":"Cassani","year":"2011","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0089","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody\u2013induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-\u03b3\u2013expressing Th1 cells and IL-17A\/IL-22\u2013expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"Tillack","year":"2014","journal-title":"Gut"},{"key":"2019042621331431600_CIT0090","first-page":"2831","article-title":"Development of psoriasis scalp with alopecia during treatment of Crohn\u2019s disease with infliximab and rapid response to both diseases to ustekinumab","volume":"17","author":"Andrisani","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2019042621331431600_CIT0091","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1684\/ejd.2011.1164","article-title":"Pustular psoriasis development after initial ustekinumab administration in chronic plaque psoriasis","volume":"21","author":"Gregoriou","year":"2011","journal-title":"Eur J Dermatol"},{"key":"2019042621331431600_CIT0092","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: Unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"2019042621331431600_CIT0093","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/09546634.2017.1329511","article-title":"Interleukin-17 inhibition: Role in psoriasis and inflammatory bowel disease","volume":"29","author":"Hohenberger","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"2019042621331431600_CIT0094","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"2019042621331431600_CIT0095","first-page":"631","article-title":"The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: A systematic review and meta-analysis","volume":"11","author":"Karreman","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2019042621331431600_CIT0096","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"key":"2019042621331431600_CIT0097","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s100670070003","article-title":"Subclinical sacroiliitis in inflammatory bowel disease: A clinical and follow-up study","volume":"19","author":"Queiro","year":"2000","journal-title":"Clin Rheumatol"},{"key":"2019042621331431600_CIT0098","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1440-1746.2007.05108.x","article-title":"Clinical and genetic factors associated with sacroiliitis in Crohn\u2019s disease","volume":"23","author":"Peeters","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"2019042621331431600_CIT0099","first-page":"2860","article-title":"Spondyloarthropathy is underestimated in inflammatory bowel disease: Prevalence and HLA association","volume":"27","author":"de Vlam","year":"2000","journal-title":"J Rheumatol"},{"key":"2019042621331431600_CIT0100","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/003655201317097173","article-title":"Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients","volume":"36","author":"Salvarani","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"2019042621331431600_CIT0101","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/ibd.20942","article-title":"Musculoskeletal manifestations of inflammatory bowel disease","volume":"15","author":"Bourikas","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331431600_CIT0102","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis [part II]: Validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0104","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/annrheumdis-2016-210747","article-title":"Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: A systematic literature review and meta-analysis","volume":"76","author":"Sepriano","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0105"},{"key":"2019042621331431600_CIT0106","first-page":"85","article-title":"Criteria of the classification of spondylarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"2019042621331431600_CIT0107","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2019042621331431600_CIT0108","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2019042621331431600_CIT0109","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0110","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.39008","article-title":"Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis","volume":"67","author":"Mease","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2019042621331431600_CIT0111","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3414\/ME12-01-0063","article-title":"The Standardization of Uveitis Nomenclature [SUN] Project. Development of a clinical evidence base utilizing informatics tools and techniques","volume":"52","author":"Trusko","year":"2013","journal-title":"Methods Inf Med"},{"key":"2019042621331431600_CIT0112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"2019042621331431600_CIT0113","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2019042621331431600_CIT0114","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331431600_CIT0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis\u2014oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"2019042621331431600_CIT0116","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/archderm.1989.01670140087017","article-title":"Assessment of disease progress in psoriasis","volume":"125","author":"Marks","year":"1989","journal-title":"Arch Dermatol"},{"key":"2019042621331431600_CIT0117","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.1991.tb04952.x","article-title":"Measurement of involved surface area in patients with psoriasis","volume":"124","author":"Ramsay","year":"1991","journal-title":"Br J Dermatol"},{"key":"2019042621331431600_CIT0118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index [EASI]: assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","author":"Hanifin","year":"2001","journal-title":"Exp Dermatol"},{"key":"2019042621331431600_CIT0119","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.MIB.0000442011.60285.68","article-title":"Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients","volume":"20","author":"Weizman","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331431600_CIT0120","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1053\/j.gastro.2014.12.030","article-title":"Identification of risk loci for Crohn\u2019s disease phenotypes using a genome-wide association study","volume":"148","author":"Alonso","year":"2015","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0121","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat Genet"},{"key":"2019042621331431600_CIT0122","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10067-015-2949-3","article-title":"Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis","volume":"34","author":"Reveille","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2019042621331431600_CIT0123","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.autrev.2016.02.002","article-title":"An update on biomarkers in axial spondyloarthritis","volume":"15","author":"Prajzlerov\u00e1","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2019042621331431600_CIT0124","first-page":"884","article-title":"Bayesian machine learning techniques for revealing complex interactions among genetic and clinical factors in association with extra-intestinal manifestations in IBD patients","volume":"2016","author":"Menti","year":"2016","journal-title":"AMIA Annu Symp Proc"},{"key":"2019042621331431600_CIT0125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/BOR.0000000000000066","article-title":"Assessment of sacroiliitis by radiographs and MRI: Where are we now?","volume":"26","author":"van Gaalen","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2019042621331431600_CIT0126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.autrev.2013.06.006","article-title":"Rheumatic manifestations in inflammatory bowel disease","volume":"13","author":"Atzeni","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2019042621331431600_CIT0127","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/ard.2011.150680","article-title":"Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI study group","volume":"71","author":"Hermann","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.15557\/JoU.2016.0018","article-title":"Diagnostic imaging of psoriatic arthritis. Part II: magnetic resonance imaging and ultrasonography","volume":"16","author":"Sudo\u0142-Szopi\u0144ska","year":"2016","journal-title":"J Ultrason"},{"key":"2019042621331431600_CIT0129","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/ard.2010.138701","article-title":"How to diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler ultrasonography","volume":"70","author":"D\u2019Agostino","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/ar2665","article-title":"Progress in spondylarthritis. Spondyloarthritis: Lessons from imaging","volume":"11","author":"Maksymowych","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2019042621331431600_CIT0131","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/art.21133","article-title":"How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?","volume":"52","author":"van der Heijde","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2019042621331431600_CIT0132","first-page":"125","article-title":"Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years","volume":"31","author":"Spoorenberg","year":"2004","journal-title":"J Rheumatol"},{"key":"2019042621331431600_CIT0133","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2004.029298","article-title":"Inflammation in ankylosing spondylitis: A systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging","volume":"64","author":"Baraliakos","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0134","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10883","article-title":"Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system","volume":"48","author":"Braun","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2019042621331431600_CIT0135","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I","article-title":"The bath ankylosing spondylitis radiology index [BASRI]: A new, validated approach to disease assessment","volume":"41","author":"MacKay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2019042621331431600_CIT0136","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: A multiparametric predictive model","volume":"72","author":"Van Praet","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2019042621331431600_CIT0137","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/ar2866","article-title":"Inflammatory bowel disease serologies in ankylosing spondylitis patients: A pilot study","volume":"11","author":"Mundwiler","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2019042621331431600_CIT0138","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar4350","article-title":"Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: An observational study","volume":"15","author":"Wallis","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2019042621331431600_CIT0139","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.MIB.0000201098.26450.ae","article-title":"Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China","volume":"12","author":"Jiang","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331431600_CIT0140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gutjnl-2013-304636","article-title":"East\u2013West gradient in the incidence of inflammatory bowel disease in Europe: The ECCO-EpiCom inception cohort","volume":"63","author":"Burisch","year":"2014","journal-title":"Gut"},{"key":"2019042621331431600_CIT0141","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.gastro.2015.09.005","article-title":"Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia","volume":"150","author":"Ng","year":"2016","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0142","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study","volume":"9","author":"Lakatos","year":"2003","journal-title":"World J Gastroenterol"},{"key":"2019042621331431600_CIT0143","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000363228","article-title":"Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking","volume":"90","author":"Roberts","year":"2014","journal-title":"Digestion"},{"key":"2019042621331431600_CIT0144","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","article-title":"Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease","volume":"10","author":"Karmiris","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2019042621331431600_CIT0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"key":"2019042621331431600_CIT0146","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3109\/00365521.2016.1140807","article-title":"Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease","volume":"51","author":"Vegh","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"2019042621331431600_CIT0147","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365521.2014.991752","article-title":"Extraintestinal manifestations in Crohn\u2019s disease and ulcerative colitis: Results from a prospective, population-based European inception cohort","volume":"50","author":"Isene","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"2019042621331431600_CIT0148","doi-asserted-by":"crossref","first-page":"12269","DOI":"10.3748\/wjg.v20.i34.12269","article-title":"Smoking increases the risk of extraintestinal manifestations in Crohn\u2019s disease","volume":"20","author":"Ott","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2019042621331431600_CIT0149","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2019042621331431600_CIT0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1572-0241.2004.04039.x","article-title":"Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis","volume":"99","author":"Manguso","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2019042621331431600_CIT0151","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2036.2008.03868.x","article-title":"The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn\u2019s disease","volume":"29","author":"Orchard","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"2019042621331431600_CIT0152","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/gast.2002.35396","article-title":"Uveitis and erythema nodosum in inflammatory bowel disease: Clinical features and the role of HLA genes","volume":"123","author":"Orchard","year":"2002","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0153","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","article-title":"Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease","volume":"118","author":"Orchard","year":"2000","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0154","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klingberg","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2019042621331431600_CIT0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cgh.2016.06.025","article-title":"Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease","volume":"15","author":"Peyrin-Biroulet","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019042621331431600_CIT0156","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/ajg.2015.355","article-title":"Vedolizumab and infliximab combination therapy in the treatment of Crohn\u2019s disease","volume":"110","author":"Hirten","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2019042621331431600_CIT0157","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2017.07.031","article-title":"American Gastroenterological Association Institute technical review on the role of therapeutic drug monitoring in the management of inflammatory bowel diseases","volume":"153","author":"Vande Casteele","year":"2017","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0158","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cgh.2015.06.001","article-title":"Defining disease severity in inflammatory bowel diseases: Current and future directions","volume":"14","author":"Peyrin-Biroulet","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019042621331431600_CIT0159","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/art.10202","article-title":"Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: Better treatments but a shortage of rheumatologists","volume":"46","author":"Pincus","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2019042621331431600_CIT0160","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1681\/ASN.2004110965","article-title":"Treatment of high-risk patients with diabetes: Motivation and teaching intervention: A randomized, prospective 8-year follow-up study","volume":"16","author":"Rachmani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2019042621331431600_CIT0161","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2337\/dc06-1406","article-title":"Glycemic and risk factor control in type 1 diabetes: Results from 13,612 patients in a national diabetes register","volume":"30","author":"Eeg-Olofsson","year":"2007","journal-title":"Diabetes Care"},{"key":"2019042621331431600_CIT0162","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus [the ADVANCE trial]: A randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"2019042621331431600_CIT0163","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease [STRIDE]: Determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2019042621331431600_CIT0164","author":"Office of Communications, Division of Drug Information, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, Maryland, USA"},{"key":"2019042621331431600_CIT0165","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"2019042621331431600_CIT0166","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004836-199201000-00005","article-title":"Quality of life in inflammatory bowel disease","volume":"14","author":"Love","year":"1992","journal-title":"J Clin Gastroenterol"},{"key":"2019042621331431600_CIT0167","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"2019042621331431600_CIT0168","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"2019042621331431600_CIT0169","volume-title":"EQ-5D User Guide: Basic Information on how to use the EQ-5D Version 2.0","author":"Cheung","year":"2009"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/13\/5\/541\/28534631\/jjy191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T05:47:48Z","timestamp":1720763268000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/13\/5\/541\/5183379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":169,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,11,15]]},"published-print":{"date-parts":[[2019,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy191","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2018,11,15]]}}}